Skip to main content Accessibility help
  • Print publication year: 2009
  • Online publication date: August 2010

Chapter 14 - Gestational trophoblastic disease and ovarian germ cell tumours

Related content

Powered by UNSILO

Further reading

MitchellH, SecklMJ. Discrepancies between commercially available immunoassays in the detection of tumour-derived hCG. Mol Cell Endocrinol 2007; 260: 310–13.
Murugaesu N, SchmidP, DanceyG, AgarwalR, HoldenL, McNeishI, SavagePM, et al. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol 2006; 24: 4862–6.
Ngan S, SecklMJ.Gestational trophoblastic neoplasia management: an update. Curr Opin Oncol 2007; 19(5): 486–91.
NogalesF, TalermanA, Kubik-HuchRA, TavassoliFA, DevouassouxM. Germ cell tumours of the ovary and peritoneum. In: TavassoliFA, DevlieeP. (eds) Tumours of the Breast and Female Genital Organs, World Health Organization Classification of Tumours. Lyon: IARC Press, Lyon 2003; 163–75.
PattersonDM, MurugaesuN, HoldenL, SecklMJ, RustinGJ. A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer 2008; 18: 43–50.
SebireNJ, SecklMJ. Gestational trophoblastic disease: current management of hydatidiform mole. BMJ 2008; 337: 454–8.